6 results
8-K
EX-99.2
DAWN
Day One Biopharmaceuticals, Inc.
30 Jul 24
Day One Reports Second Quarter 2024 Financial Results and Corporate Progress
7:35am
to value creation, potential first-in-class DAY301 ADC targeting PTK7 Building a Sustainable Company with Durable Growth for the Near and Long Term
8-K
EX-99.1
DAWN
Day One Biopharmaceuticals, Inc.
8 Jan 24
Regulation FD Disclosure
8:30am
with a 16 BRAF V600E mutation who require systemic therapy based on a study with the same primary endpoint.
Pillars for Sustainable Growth to Drive Long
PRE 14A
DAWN
Day One Biopharmaceuticals, Inc.
18 Apr 23
Preliminary proxy
4:05pm
”) initiatives are important to our business and to creating sustainable value for our stockholders and wider stakeholder group. Our board of directors … operate.
Social and Ethical Practices
We believe that CSR initiatives are important to our business and to creating sustainable value for our
DEF 14A
1w0e 8r4nwsn8c
28 Apr 22
Definitive proxy
4:44pm
- Prev
- 1
- Next